ENvue Medical, Inc. (FEED)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue Annual

0 900K 1.8M 2.7M FY14: 203K FY15: 147K FY16: 229K FY17: 239K FY18: 318K FY19: 530K FY20: 623K FY21: 1.7M FY22: 752K FY23: 2.3M FY24: 2.6M FY25: 2.6M FY15 FY17 FY19 FY21 FY23 FY25

Gross Profit Annual

0 600K 1.2M 1.8M FY14: 110K FY15: 98K FY16: 141K FY17: 151K FY18: 160K FY19: 281K FY20: 214K FY21: 770K FY22: 167K FY23: 1.5M FY24: 1.5M FY25: 153K FY15 FY17 FY19 FY21 FY23 FY25

Operating Income Annual

-24M -16M -8M 0 8M 16M 24M FY14: -1.2M FY15: -1.4M FY16: -2.3M FY17: -3.1M FY18: -4.3M FY19: -5.2M FY20: -4.7M FY21: -5.7M FY22: -5M FY23: -3.4M FY24: -3.6M FY25: -22.9M FY15 FY17 FY19 FY21 FY23 FY25

Net Income Annual

-21M -14M -7M 0 7M 14M 21M FY14: -2.6M FY15: -2.9M FY16: -2.8M FY17: -5M FY18: -4.2M FY19: -5.8M FY20: -4.3M FY21: -14.3M FY22: -5.4M FY23: -3.7M FY24: -3.7M FY25: -18.2M FY15 FY17 FY19 FY21 FY23 FY25

Cost of Revenue Annual

0 900K 1.8M 2.7M FY14: 93K FY15: 49K FY16: 88K FY17: 88K FY18: 158K FY19: 249K FY20: 409K FY21: 925K FY22: 585K FY23: 746K FY24: 1.1M FY25: 2.4M FY15 FY17 FY19 FY21 FY23 FY25

Operating Cash Flow Annual

-10.5M -7M -3.5M 0 3.5M 7M 10.5M FY14: -900K FY15: -1.5M FY16: -1.5M FY17: -2.2M FY18: -3.5M FY19: -3.9M FY20: -3.4M FY21: -4.4M FY22: -7M FY23: -3.6M FY24: -2.5M FY25: -9.4M FY15 FY17 FY19 FY21 FY23 FY25

Free Cash Flow Annual

-10.5M -7M -3.5M 0 3.5M 7M 10.5M FY14: -904K FY15: -1.5M FY16: -1.5M FY18: -3.6M FY20: -3.4M FY21: -4.4M FY22: -7M FY23: -3.6M FY24: -2.5M FY25: -9.4M FY14 FY15 FY16 FY18 FY20 FY21 FY22 FY23 FY24 FY25

Operating cash flow minus capital expenditure.

Shares Outstanding Annual

0 500K 1M 1.5M FY21: 1.3M FY22: 1.4M FY23: 159.1K FY24: 27K FY25: 628.5K FY21 FY22 FY23 FY24 FY25

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-210.00 -140.00 -70.00 0.00 70.00 140.00 210.00 Q4 '14: -17.07 Q1 '15: -14.68 Q2 '15: -11.05 Q3 '15: -6.34 Q4 '15: -1.34 Q1 '16: -0.60 Q2 '16: -0.63 Q3 '16: -0.53 Q4 '16: -0.62 Q1 '17: -0.88 Q2 '17: -0.93 Q3 '17: -1.15 Q4 '17: -1.16 Q1 '18: -0.91 Q2 '18: -0.86 Q3 '18: -0.72 Q4 '18: -0.64 Q1 '19: -0.92 Q2 '19: -0.95 Q3 '19: -0.86 Q4 '19: -0.85 Q1 '20: -0.58 Q2 '20: -0.62 Q3 '20: -0.60 Q4 '20: -0.42 Q1 '21: -0.49 Q2 '21: -0.30 Q3 '21: -0.46 Q4 '21: -0.57 Q1 '22: -1.18 Q2 '22: -2.10 Q3 '22: -2.52 Q4 '22: -3.84 Q1 '23: -3.70 Q2 '23: -3.42 Q3 '23: -3.16 Q4 '23: -23.33 Q1 '24: -20.28 Q2 '24: -46.81 Q3 '24: -49.95 Q4 '24: -157.28 Q1 '25: -189.56 Q1 '16 Q3 '17 Q1 '19 Q3 '20 Q1 '22 Q3 '23 Q1 '25

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.